BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16556732)

  • 1. Identification of structural determinants for G protein-independent activation of mitogen-activated protein kinases in the seventh transmembrane domain of the angiotensin II type 1 receptor.
    Yee DK; Suzuki A; Luo L; Fluharty SJ
    Mol Endocrinol; 2006 Aug; 20(8):1924-34. PubMed ID: 16556732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent behavioral roles of angiotensin receptor intracellular signaling cascades.
    Daniels D; Yee DK; Faulconbridge LF; Fluharty SJ
    Endocrinology; 2005 Dec; 146(12):5552-60. PubMed ID: 16123155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways.
    Hines J; Fluharty SJ; Yee DK
    Biochem Pharmacol; 2003 Jul; 66(2):251-62. PubMed ID: 12826267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts.
    Aplin M; Christensen GL; Schneider M; Heydorn A; Gammeltoft S; Kjølbye AL; Sheikh SP; Hansen JL
    Basic Clin Pharmacol Toxicol; 2007 May; 100(5):289-95. PubMed ID: 17448113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of ERK, JNK, Akt, and G-protein coupled signaling by hybrid angiotensin II AT1/bradykinin B2 receptors expressed in HEK-293 cells.
    Yu J; Lubinsky D; Tsomaia N; Huang Z; Taylor L; Mierke D; Navarro J; Miraz O; Polgar P
    J Cell Biochem; 2007 May; 101(1):192-204. PubMed ID: 17212359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling.
    Gáborik Z; Jagadeesh G; Zhang M; Spät A; Catt KJ; Hunyady L
    Endocrinology; 2003 Jun; 144(6):2220-8. PubMed ID: 12746278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of agonist-induced signaling and regulation of the angiotensin AT1 receptor.
    Hunyady L; Gáborik Z; Shah BH; Jagadeesh G; Clark AJ; Catt KJ
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):89-100. PubMed ID: 15134806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction.
    Reis RI; Santos EL; Pesquero JB; Oliveira L; Schanstra JP; Bascands JL; Pecher C; Paiva AC; Costa-Neto CM
    Regul Pept; 2007 Apr; 140(1-2):32-6. PubMed ID: 17239455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
    Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts.
    Liu B; Yu J; Taylor L; Zhou X; Polgar P
    J Cell Biochem; 2006 Apr; 97(5):1104-20. PubMed ID: 16294326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of Ca(2+) and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2.
    Frank GD; Saito S; Motley ED; Sasaki T; Ohba M; Kuroki T; Inagami T; Eguchi S
    Mol Endocrinol; 2002 Feb; 16(2):367-77. PubMed ID: 11818507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidic acid regulates signal output by G protein coupled receptors through direct interaction with phospholipase C-beta(1).
    Litosch I; Pujari R; Lee SJ
    Cell Signal; 2009 Sep; 21(9):1379-84. PubMed ID: 19414067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor.
    Proulx CD; Holleran BJ; Boucard AA; Escher E; Guillemette G; Leduc R
    Mol Pharmacol; 2008 Sep; 74(3):552-61. PubMed ID: 18509066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
    Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
    J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.
    Zahradka P; Litchie B; Storie B; Helwer G
    Endocrinology; 2004 Jun; 145(6):2978-87. PubMed ID: 14976148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes.
    Aplin M; Christensen GL; Schneider M; Heydorn A; Gammeltoft S; Kjølbye AL; Sheikh SP; Hansen JL
    Basic Clin Pharmacol Toxicol; 2007 May; 100(5):296-301. PubMed ID: 17448114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT(1A) receptor.
    Costa-Neto CM; Miyakawa AA; Oliveira L; Hjorth SA; Schwartz TW; Paiva AC
    Br J Pharmacol; 2000 Jul; 130(6):1263-8. PubMed ID: 10903964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene.
    Santos EL; Reis RI; Silva RG; Shimuta SI; Pecher C; Bascands JL; Schanstra JP; Oliveira L; Bader M; Paiva AC; Costa-Neto CM; Pesquero JB
    Regul Pept; 2007 Jun; 141(1-3):159-67. PubMed ID: 17320985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single mutations at Asn295 and Leu305 in the cytoplasmic half of transmembrane alpha-helix domain 7 of the AT1 receptor induce promiscuous agonist specificity for angiotensin II fragments: a pseudo-constitutive activity.
    Feng YH; Zhou L; Qiu R; Zeng R
    Mol Pharmacol; 2005 Aug; 68(2):347-55. PubMed ID: 15901848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally selective AT(1) receptor activation reduces ischemia reperfusion injury.
    Hostrup A; Christensen GL; Bentzen BH; Liang B; Aplin M; Grunnet M; Hansen JL; Jespersen T
    Cell Physiol Biochem; 2012; 30(3):642-52. PubMed ID: 22854413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.